German drugmaker BioNTech plans to develop its first malaria vaccine and begin clinical trials by next year.
The ambitious turnaround time is thanks to the MRNA technology used to develop the Pfizer and Moderna coronavirus vaccines in under a year.
The only approved malaria vaccine, Mosquirix, took scientists at GlaxoSmithKline more than 30 years to develop.
Malaria kills more than 400,000 people annually, most of them children in sub-Saharan Africa.
Apart from vaccines and pills, countries - including Malawi, Tanzania and Kenya - use drones to find mosquito breeding grounds and kill the larvae before they hatch.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Woman dies after being set on fire on NYC subway
50 minutes -
Elon Musk’s curious fixation with Britain
55 minutes -
EBID wins the Africa Sustainability Award
3 hours -
Expansion Drive: Takoradi Technical University increases faculties
7 hours -
SHS heads demand payment of outstanding funds before reopening of schools
8 hours -
We thank God for the 2024 general elections – Akufo-Addo
8 hours -
Coconut Grove Beach Resort marks 30 years of excellence with memorable 9 lessons & carols service
8 hours -
WAFU B U-17 Girls’ Cup: Black Maidens beat Nigeria on penalties to win inaugral tournament
9 hours -
Real Madrid beat Sevilla to keep pressure on leaders Atletico
10 hours -
Liverpool put six past Spurs to go four points clear
10 hours -
Manchester United lose 3-0 at home to Bournemouth yet again
10 hours -
CHAN 2024Q: ‘It’s still an open game’ – Didi on Ghana’s draw with Nigeria
10 hours -
CHAN 2024Q: Ghana’s Black Galaxies held by Nigeria in first-leg tie
11 hours -
Dr Nduom hopeful defunct GN bank will be restored under Mahama administration
12 hours -
Bridget Bonnie celebrates NDC Victory, champions hope for women and youth
12 hours